Clinical Trials Browser

Phase 2 × Ependymoma × antineoplaston AS 2-1 × Clear all

NCT00003479 2022-02-23

Antineoplaston Therapy in Treating Patients With Ependymoma

Phase 2 Terminated

9 enrolled 6 charts

Ependymoma